Product description

KioMedine(vs)one is a unique soft implant for OsteoArthritis pain relief and outstanding response rate
KioMedine(vs)one is the new generation single-shot injection intended for the symptomatic treatment of knee osteoarthritis based on world-first exclusive animal-free KiOmedine® CM Chitosan.
  • Treatment response up to 76%
  • 86% of patient satisfied
  • 90% of physicians satisfied
KiOmedine® CM Chitosan is a patented technology made in Belgium, resulting from years of research and innovation. Thanks to a unique structure that differs from hyaluronic acid and natural chitosanKioMedine(vs)one has an exclusive dual mechanism of action : improves lubrication and protect the endogenous synovial components thanks to its unprecedented free radical scavenging capacity. 

Read more


CAS Registry Number 05404023514004
Categories Finished Dosage FormsInjectables; Pharmaceutical Machinery & TechnologyMedical Devices
Sales markets Western Europe; Eastern Europe; Asia; North America; Africa; Central/South America
Supplied from Belgium

Products from other suppliers